EBOS Group Limited (NZE:EBO)

Market Cap	5.65B
Revenue (ttm)	13.24B
Net Income (ttm)	232.16M
Shares Out	205.03M
EPS (ttm)	1.18
PE Ratio	23.41
Forward PE	18.32
Dividend	1.26 (4.59%)
Ex-Dividend Date	Sep 4, 2025

Volume	290,591
Average Volume	217,445
Open	27.50
Previous Close	27.50
Day's Range	27.42 - 27.70
52-Week Range	26.86 - 42.55
Beta	0.25
RSI	45.18
Earnings Date	Feb 18, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 5,770
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.

Financial numbers in AUD